ArticleGastroenterology research and practice2016

Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1.

Joo Young Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.